Emily Thrash

8PUBLICATIONS
55CO-AUTHORS
Innate immunityHaematological tumoursCellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell-Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic Melanoma.

F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie

|Nov 07, 2021
A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia.

Deepti Gadi, Alec Griffith, Svitlana Tyekucheva

|Aug 25, 2021
Coevolving JAK2V617F+relapsed AML and donor T cells with PD-1 blockade after stem cell transplantation: an index case.

Livius Penter, Satyen H Gohil, Teddy Huang

|Jul 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.

Bita Sahaf, Mina Pichavant, Brian H Lee

|Mar 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.

Livius Penter, Yi Zhang, Alexandra Savell

|Mar 08, 2021
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia.

Ishwarya Murali, Siddha Kasar, Aishath Naeem

Pageof 2

Frequent Collaborators

3 joint publications

Sacha Gnjatic

3 joint publications

Jennifer R Brown

2 joint publications

Jerome Ritz

2 joint publications

Kenneth J Livak